EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Evaluation of the management of Clostridioides difficile infection as a risk factor for recurrence. A retrospective observational study

J M Barbero Allende, I Ureña, L Cañivano, S García, C Paz, A Olmo-Ruiloba, K Jauregi, S Coronado, L López Requejo, L Porcel, V Perea, M Irigoyen und 11 weitere

Revista Española de Quimioterapia · 2025

DOI: 10.37201/req/086.2024 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Revista Española de Quimioterapia, 2025. Verfasst von J M Barbero Allende und 22 weiteren Autor:innen. Beteiligte Einrichtung: José Mª Barbero Allende. Servicio de Medicina Interna. Hospital Universitario Príncipe de Asturias. Alcalá de Henares (Spain). j_m_barbero@yahoo.es. Hauptthemen laut MEDLINE: Clostridium Infections, Anti-Bacterial Agents. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

One of the main problems with Clostridioides difficile infection (CDI) is its tendency to recur. The objective of the study is to analyze which factors in the clinical management of CDI favor recurrence. Material and methods. This is a retrospective study conducted at the Hospital Universitario Príncipe de Asturias on cases of CDI between January 2021 and June 2023. Demographic variables, comorbidities, risk factors for recurrence, and treatments used for CDI were recorded. Non-optimal clinical management was defined as: not discontinuing treatment with proton pump inhibitors (PPIs) if the patient was on them, not discontinuing concomitant antibiotic treatments if the patient was on these, the use of metronidazole monotherapy in any case, or the use of standard-dose vancomycin if there were risk factors for recurrence.

Results

A total of 327 cases were found in 256 patients. 69 patients died within 8 weeks after the episode (26.9%). Among the remaining 258 episodes, there were 68 recurrences (26.3%). Of these 68 recurrences, 63 cases received nonoptimal treatment (93.2%), compared to 112/190 (58.9%) among those who did not recur. In the multivariate analysis adjusted for confounding factors, patients who received optimal treatment had an 89% lower risk of recurrence compared to those who did not receive it (OR 0.1; p < 0.001).

Conclusions

Reducing the use of PPIs and antibiotics and prioritizing more effective treatments against CDI could improve the recurrence rates of this infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridium InfectionsAnti-Bacterial AgentsHumansRetrospective StudiesMaleFemaleRisk FactorsAgedMiddle AgedRecurrenceAged, 80 and overVancomycinProton Pump InhibitorsMetronidazoleAdultClostridioides difficile

Stichwörter der Autor:innen

Clostridioides difficile infectionbezlotoxumabfidaxomicinrecurrence

Substanzen

Anti-Bacterial AgentsVancomycinProton Pump InhibitorsMetronidazole

Autor:innen und Institutionen

  • José Mª Barbero Allende. Servicio de Medicina Interna. Hospital Universitario Príncipe de Asturias. Alcalá de Henares (Spain). j_m_barbero@yahoo.es.

Zitieren

APA

Barbero Allende, J. M., Ureña, I., Cañivano, L., García, S., Paz, C., Olmo-Ruiloba, A., Jauregi, K., Coronado, S., López Requejo, L., Porcel, L., Perea, V., Irigoyen, M., Cano, J., García, A., León, E., Fernández-Domingo, N., Lanchares, P., Lino, B., Ortolá, M., …, & Arévalo-Serrano, J. (2025). Evaluation of the management of Clostridioides difficile infection as a risk factor for recurrence. A retrospective observational study. Revista Española de Quimioterapia. https://doi.org/10.37201/req/086.2024

Vancouver

Barbero Allende JM, Ureña I, Cañivano L, García S, Paz C, Olmo-Ruiloba A, et al. Evaluation of the management of Clostridioides difficile infection as a risk factor for recurrence. A retrospective observational study. Revista Española de Quimioterapia. 2025. doi:10.37201/req/086.2024

BibTeX
@article{BarberoAllende2025,
  author = {Barbero Allende, J M and Ureña, I and Cañivano, L and García, S and Paz, C and Olmo-Ruiloba, A and Jauregi, K and Coronado, S and López Requejo, L and Porcel, L and Perea, V and Irigoyen, M and Cano, J and García, A and León, E and Fernández-Domingo, N and Lanchares, P and Lino, B and Ortolá, M and Lizasoain, A and Sánchez, V and Arévalo-Cañas, C and Arévalo-Serrano, J},
  title = {Evaluation of the management of Clostridioides difficile infection as a risk factor for recurrence. A retrospective observational study},
  journal = {Revista Española de Quimioterapia},
  year = {2025},
  doi = {10.37201/req/086.2024}
}
Kostenlos starten →